The present disclosure relates to a method of extracting circulating tumor cells (CTCs) from a blood sample from a human subject. This method includes adding a hyaluronan degrading enzyme to a blood sample from a subject in order to remove hyaluronan from the surface of the CTCs, bringing a CTC-capturing agent in contact with the CTCs and separating captured CTCs from the blood sample.
